Treatment of osteonecrosis of the femoral head by botulinum toxin type A injection to the psoas muscle: A case report
Anesthesia and Pain Medicine
;
: 85-90, 2017.
Artículo
en Inglés
| WPRIM
| ID: wpr-21257
ABSTRACT
Osteonecrosis of the femoral head (ONFH) can cause femoral head depression and cortical discontinuity. Treatment for ONFH remains challenging. We performed botulinum toxin type A injection to psoas major muscle in five patients with radiological femoral head collapse (Association Research Circulation Osseus classification stage III) who were non-responsive after two years of conservative treatment (tramadol 200 mg/day, mefenamic acid 1,000 mg/day). At two weeks after the procedure, their mean hip pain was decreased from 88 ± 0.4/100 mm to 22 ± 0.4/100 mm based on visual analogue scale (VAS). The pain was maintained at a minimum of 20/100 mm and a maximum of 30/100 mm in VAS for at least six weeks after the procedure. These values were mean ± SD. These patients were followed-up for 6 months. There was no exacerbation of pain from repeated (three times) botulinum toxin type A injection to the psoas major muscle.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Osteonecrosis
/
Toxinas Botulínicas
/
Ácido Mefenámico
/
Músculos Psoas
/
Clasificación
/
Toxinas Botulínicas Tipo A
/
Depresión
/
Necrosis de la Cabeza Femoral
/
Cabeza
/
Cadera
Límite:
Humanos
Idioma:
Inglés
Revista:
Anesthesia and Pain Medicine
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS